BCK Partners’s Exelixis EXEL Stock Holding History

BCK Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,920	Closed	-$203K	–	28
2025 Q3	$203K	Hold	4,920	–	–	0.11%	26
2025 Q2	$217K	Buy	+4,920	New	+$197K	0.13%	25

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCK Partners's EXEL Position: Q4 2025 in Review

BCK Partners sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 4,920 shares — an estimated $203K sold.

BCK Partners first reported a position in EXEL in Q2 2025 and held it in 2 quarters. The position peaked at $217K in Q2 2025. 683 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.

BCK Partners reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
BCK Partners sold 4,920 Exelixis shares in Q4 2025, an estimated $203K.
BCK Partners first reported a position in Exelixis in Q2 2025 and held it in 2 quarters.
BCK Partners's Exelixis position peaked at $217K in Q2 2025.
683 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.

Based on BCK Partners's 13F filing for Q4 2025, filed 28 Jan 2026.